“Gut Health Is Just a Better Way of Eating” – Bio&Me’s Jon Walsh on Fibre Coming Back Into Fashion

Why It Matters

The rapid growth validates a lasting consumer shift toward gut‑health nutrition, proving that high‑fibre CPG brands can achieve scale and profitability in a market once seen as niche.

Key Takeaways

• Bio&Me hit £20 m ($26.8 m) sales, 45% YoY growth
• Repeat purchase rates exceed 40% across core product lines
• New convenience formats include bars, porridge pots, and kefir drinks
• Company turned profitable last year, targeting “positive break‑even” model
• Plans focus on UK market, e‑commerce, and modest pricing premium (~10%)

Pulse Analysis

The post‑pandemic era has accelerated consumer interest in gut health, turning fibre from a dietary afterthought into a mainstream selling point. Influencers such as Tim Spector and growing social‑media trends around "fibre‑maxxing" have demystified the benefits of diverse plant fibers, prompting shoppers to seek convenient, evidence‑based solutions. This cultural shift is reshaping grocery aisles, with high‑fibre products now occupying premium shelf space alongside traditional staples.

Bio&Me has leveraged this momentum by pairing product innovation with a clear distribution strategy. By securing shelf space in the UK’s largest chains and launching on‑the‑go formats—granola bars, porridge pots, and kefir drinks—the brand meets the dual consumer demands for health and convenience. Its repeat‑purchase rate above 40% signals strong brand loyalty, while a modest 10% price premium keeps the offering competitive against legacy cereal manufacturers that have raised prices multiple times in recent years. The company’s B‑Corp certification and partnership with Bowel Cancer UK further reinforce its purpose‑driven positioning, appealing to values‑conscious shoppers.

Looking ahead, Bio&Me’s disciplined focus on the UK market and e‑commerce expansion suggests a roadmap for sustainable growth. As consumers become more sophisticated, demand for transparent, evidence‑backed fibre claims will rise, pushing the category toward greater scientific validation. While international expansion remains on the horizon, the brand’s profitability and strong retailer relationships provide a solid platform for scaling. Competitors will need to match Bio&Me’s blend of product efficacy, price accessibility, and purpose to capture a share of the burgeoning gut‑health market.